Puma Biotechnology, Inc.PBYINASDAQ
Loading
Year-over-year research & development expense growth
Latest
12.98%
↑ 228% vs avg
Percentile
P79
Within normal range
Streak
3 yr
Consecutive growthAccelerating
Average
-10.17%
Historical baseline
| Period | Value |
|---|---|
| 2025 | 12.98% |
| 2024 | 9.04% |
| 2023 | -3.56% |
| 2022 | -27.31% |
| 2021 | -26.40% |
| 2020 | -26.50% |
| 2019 | -19.44% |
| 2018 | -20.64% |
| 2017 | -6.73% |
| 2016 | 6.86% |